About Johnson & Johnson
Johnson & Johnson is a health care company based in New Brunswick, New Jersey, that researches, makes, and sells medicines and medical technology. It works through two segments: Innovative Medicine, covering prescription drugs in areas such as cancer, immune disorders, and neuroscience, and MedTech, covering devices for surgery, orthopedics, heart care, and vision. Joaquin Duato serves as chief executive. The company was founded in 1886 by Robert Wood Johnson and his brothers. In 2023 it spun off its consumer health business as Kenvue, leaving it focused on medicines and medical devices.
White House nominates four crypto-savvy regulators for CFTC and SEC seats
The nominations could accelerate regulatory clarity in the crypto sector, impacting market dynamics and innovation amid evolving oversight.
Lumen Technologies plans to mine its old copper network as it pivots to AI
Lumen's pivot to AI and copper mining highlights a strategic shift towards future-proofing its business, emphasizing innovation over legacy systems.
Agility Robotics lists on Nasdaq as first US pure-play humanoid robot company
Agility Robotics' Nasdaq listing could redefine investment in humanoid robotics, setting a benchmark for the sector's commercial viability.
Louvre Abu Dhabi opens its doors to digital assets and AI for the first time with Proof of Talk
Abu Dhabi, United Arab Emirates, 3rd November 2026, Chainwire
Securitize expands tokenized US stock offering to 25 equities
Securitize's expansion into tokenized equities could accelerate blockchain adoption in finance, challenging traditional market structures.
Microsoft’s jumbo debt sale draws more than €115 billion in demand
Microsoft's debt sale success highlights investor confidence in AI infrastructure growth, potentially spurring similar moves by other tech giants.
A sourced map of Johnson & Johnson's relationships is on the way.
Partners, competitors and related assets, each link independently verified and source-linked before it appears here.
The Crypto Briefing podcast is on the way.
Conversations on Johnson & Johnson and the wider market, hosted by our team, will appear here once episodes are live.